Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...

Please provide your email address to receive an email when new articles are posted on . Circulatory death livers preserved for donation with normothermic machine perfusion had the lowest early ...

XI'AN, Feb. 5 (Xinhua) -- A Chinese research team has successfully used a gene-edited pig liver in an extracorporeal perfusion therapy to treat a patient with acute liver failure, saving the patient's ...

Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved clinical outcomes and reduced use of hospital resources compared with static cold ...

Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the idea of 3D bioprinting.

The MarketWatch News Department was not involved in the creation of this content. Updated Press Release: An earlier version of this announcement was inadvertently ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver ...

CHICAGO, Sept. 18, 2025 /PRNewswire/ -- The first-ever multicenter study of Hypothermic Oxygenated Perfusion (HOPE) in pediatric liver transplantation—using any machine perfusion device— was presented ...

FDA-cleared labeling supports broad clinical applicability, including Donation after Circulatory Death (DCD) donors, and positions VitaSmart™ as a scalable and economically compelling platform for U.S ...